NAVAN, Inc. (NAVAN), a privately-held biotechnology company enabling the development of next generation cell and gene therapies through its novel, non-viral NanoStraw platform, announced today the appointment Heidi Hagen, Co-founder and Chief Strategy Officer for Vineti, Inc., and Howard Grimes, Ph.D., Associate Vice President and Associate Vice Provost for Institutional Initiatives at The University of Texas at San Antonio, to its Strategic Advisory Board.
{iframe}https://www.fltimes.com/business/national/navan-appoints-cell-therapy-executive-and-agbio-expert-to-strategic/article_165a5918-d4e5-57d5-ac05-d95527a8942f.html{/iframe}